XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Earnings Per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share, Basic and Diluted | A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Numerator: |  |  |  |  |  |  |
Net loss attributable to Surgery Partners, Inc. | $ | (25.0) |  |  | $ | (22.9) |  |  | $ | (31.2) |  |  | $ | (70.8) |
Less: amounts allocated to participating securities (1) | — |  |  | — |  |  | — |  |  | (10.3) |
Net loss attributable to common stockholders | $ | (25.0) |  |  | $ | (22.9) |  |  | $ | (31.2) |  |  | $ | (81.1) |
Denominator: |  |  |  |  |  |  |
Weighted average shares outstanding- basic | 88,907 |  |  | 80,726 |  |  | 88,604 |  |  | 68,350 |
Weighted average shares outstanding- diluted (2) | 88,907 |  |  | 80,726 |  |  | 88,604 |  |  | 68,350 |
Loss per share: |  |  |  |  |  |  |
Basic | $ | (0.28) |  |  | $ | (0.28) |  |  | $ | (0.35) |  |  | $ | (1.19) |
Diluted (2) | $ | (0.28) |  |  | $ | (0.28) |  |  | $ | (0.35) |  |  | $ | (1.19) |
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive: |  |  |  |  |  |  |
Stock options | 1,323 |  |  | 1,974 |  |  | 1,527 |  |  | 1,927 |
Restricted shares | 604 |  |  | 1,461 |  |  | 669 |  |  | 1,444 |
(1)Includes dividends accrued for the Series A Preferred Stock for the nine months ended September 30, 2021. The Series A Preferred Stock did not participate in undistributed losses and was converted to common stock during the second quarter of 2021. There were no participating securities for the three and nine months ended September 30, 2022 and the three months ended Septemberer 30, 2021. (2)The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration